More recently, a combinatorial therapy with conventional chemotherapeutic agent and the anti-diabetic drug metformin has been shown to efficiently eliminate drug-resistant CD44+/CD24− cancer stem/progenitor cells in breast cancers [74, 75]. Here, CD44 is linked to breast carcinoma.